Viewing Study NCT01062620


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2025-12-26 @ 3:30 AM
Study NCT ID: NCT01062620
Status: COMPLETED
Last Update Posted: 2011-09-15
First Post: 2010-02-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer
Sponsor: Axelar AB
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module